P04.19 Detailed analysis of mutation change after treatment in glioblastoma

BACKGROUND: Glioblastoma (GBM) is poor-prognosis cancer and tumor recurrence is inevitable despite intensive chemoradiotherapy. Thus, insights into the mechanism of tumor recurrence are critical for improved patient treatment. Here, we describe our integrated genomic analyses using next-generation s...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Nagane, M, Saito, K, Shimizu, S, Nozaki, E, Kobayashi, K, Kume, S, Chiba, T, Shibahara, J, Shiokawa, Y
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Poster Presentations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144212/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.253
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak